Format

Send to:

Choose Destination
See comment in PubMed Commons below
Br J Cancer. 2006 Jul 17;95(2):131-8.

Management of advanced colorectal cancer: state of the art.

Author information

  • 1Christie Hospital NHS Trust, Wilmslow Road, Manchester M20 4BX, UK. mark.saunders@christie-tr.nwest.nhs.uk

Abstract

Colorectal cancer (CRC) caused over 500 000 deaths worldwide in 2002. Recent advances in the treatment of advanced disease include the incorporation of two new cytotoxic agents, irinotecan and oxaliplatin, into first-line regimens. The concept of planned sequential therapy involving three active agents during the course of a patient's treatment is evolving. Coupled with the integrated use of targeted monoclonal antibodies, we can now expect overall survival rates for advanced disease to exceed 20 months. This review considers current treatments and suggests where future progress may occur.

PMID:
16835584
[PubMed - indexed for MEDLINE]
PMCID:
PMC2360624
Free PMC Article
PubMed Commons home

PubMed Commons

0 comments
How to join PubMed Commons

    Supplemental Content

    Full text links

    Icon for Nature Publishing Group Icon for PubMed Central
    Loading ...
    Write to the Help Desk